EnVisio System for Surgical Guidance
Soft Tissue Localization (e.g., Breast Cancer Surgery)
Key Facts
About Elucent Medical
Elucent Medical, founded in 2015 and based in Minneapolis, is pioneering a new standard in surgical oncology with its EnVisio System. The technology platform integrates an implantable SmartClip marker, an attachable SmartSensor, and a SmartSurface field generator to deliver continuous, true 3D surgical awareness, aiming to improve the precision of tumor removal. The company is commercializing its system for soft tissue localization, initially in breast cancer surgery, with endorsements from key surgical centers. As a private, likely venture-backed firm, Elucent is positioned in the high-growth surgical guidance market but faces competition and the challenge of driving widespread clinical adoption.
View full company profile